Oruka Therapeutics (ORKA) Cash from Operations (2010 - 2026)
Oruka Therapeutics (ORKA) posted quarterly Cash from Operations of 23578000.0 for Q1 2026, down 12.98% year-over-year from 27095224.78 in Q1 2025, and down 4.28% quarter-over-quarter from 22610000.0 in Q4 2025.
Oruka Therapeutics (ORKA) Cash from Operations (2010 - 2026) Analysis & Trends
Oruka Therapeutics' Cash from Operations history runs 17 years deep, the most recent figure standing at 23578000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 12.98% year-over-year to 23578000.0; the TTM figure through Mar 2026 stood at 90919000.0 (down 15.76% YoY), while the FY2025 annual figure was 88210000.0, down 52.51% from the prior year.
- Cash from Operations for Q1 2026 stood at 23578000.0, down from 22610000.0 in the prior quarter.
- The five-year high for Cash from Operations was 168000.0 in Q1 2024, with the low at 27818000.0 in Q3 2024.
- The 5-year median for Cash from Operations is 4298000.0 (2022), against an average of 10914764.71.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations soared 89.47% in 2024, then plunged 12322.02% in 2025.
- Oruka Therapeutics' Cash from Operations stood at 1494000.0 in 2022, then rose by 29.32% to 1056000.0 in 2023, then sank by 1682.01% to 18818000.0 in 2024, then declined by 20.15% to 22610000.0 in 2025, then dropped by 4.28% to 23578000.0 in 2026.
- Business Quant data shows ORKA's Cash from Operations at 23578000.0 in Q1 2026, 22610000.0 in Q4 2025, and 21586000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Oruka Therapeutics | 6.98 Bn | 5.25 Bn | - | -33.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33.15 Mn |
| Jun 30, 2026 | -33.15 Mn |
| Mar 31, 2026 | -23.58 Mn |
| Mar 31, 2026 | -23.58 Mn |
| Dec 31, 2025 | -22.61 Mn |
| Dec 31, 2025 | -22.61 Mn |
| Sep 30, 2025 | -21.59 Mn |
| Sep 30, 2025 | -21.59 Mn |
| Jun 30, 2025 | -23.15 Mn |
| Jun 30, 2025 | -23.15 Mn |
| Mar 31, 2025 | -20.87 Mn |
| Mar 31, 2025 | -20.87 Mn |
| Dec 31, 2024 | -18.82 Mn |
| Dec 31, 2024 | -18.82 Mn |
| Sep 30, 2024 | -27.82 Mn |
| Sep 30, 2024 | -27.82 Mn |
| Jun 30, 2024 | -11.03 Mn |
| Jun 30, 2024 | -11.03 Mn |
| Mar 31, 2024 | -168,000.00 |
| Mar 31, 2024 | -168,000.00 |